Skip to content

Clinical trials

Glucose Metabolism Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Metabolism Disorders Country / region: Canada Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20091
20102
20141
20171
20183
20191
20202
20212
20222
20233
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting5
Recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Ultragenyx Pharmaceutical Inc4
Eli Lilly and Company3
CRISPR Therapeutics AG2
Pfizer2
Takeda2
University of Calgary2
Akcea Therapeutics1
Anne-Sophie Brazeau1
Laval University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Metabolism Disorders26
Metabolic Diseases18
Endocrine System Diseases16
Diabetes Mellitus14
Diabetes Mellitus, Type 213
Diabetes Mellitus, Type 15
Glycogen Storage Disease Type I5
Autoimmune Diseases4
Immune System Diseases4
Obesity3

Trials

Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.